Skip to main content

/ MaRS/ Group items tagged prostate

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

FDA clears Segasist Prostate Auto-Contouring Software - PR Newswire - October 20, 2011 - 0 views

www.prnewswire.com/...ouring-software-132232953.html

Life Science Healthcare Clients Segasist software IT Medical Devices

shared by Assunta Krehl on 24 Nov 11 - No Cached

Assunta Krehl on 24 Nov 11

Segasist Technologies, a MaRS Discovery District Client, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Prostate Auto-Contouring software 'Segasist P-AC'.

<div class="cArrow"> </div><div class="cContentInner">Segasist Technologies, a MaRS Discovery District Client, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Prostate Auto-Contouring software 'Segasist P-AC'.</div>

...

Cancel

Toronto firm wins award for less-invasive prostate cancer therapy -The Star - May 23, 2010 - 0 views

www.healthzone.ca/...vasive-prostate-cancer-therapy

Clients & Tenants Life Sciences awards & competitions OCE Premier's Catalyst Award

shared by Assunta Krehl on 26 May 10 - Cached

Assunta Krehl on 26 May 10

Profound Medical Inc, a MaRS client hopes to improve quality of life for men with prostate cancer by developing a faster, more precise treatment aimed at reducing side effects. Profound Medical won the $200,000 Premier's Catalyst Award for a start-up company with the best innovation. Avenir Medical Inc, a MaRS Client was named Ontario's Next Top Entrepreneur at the conference of the Ontario Centres of Excellence.

<div class="cArrow"> </div><div class="cContentInner">Profound Medical Inc, a MaRS client hopes to improve quality of life for men with prostate cancer by developing a faster, more precise treatment aimed at reducing side effects. Profound Medical won the $200,000 Premier's Catalyst Award for a start-up company with the best innovation. Avenir Medical Inc, a MaRS Client was named Ontario's Next Top Entrepreneur at the conference of the Ontario Centres of Excellence. </div>

...

Cancel

Clinical trial first for less invasive procedure to treat prostate cancer - The Globe a... - 0 views

www.theglobeandmail.com/...article11540794

Clients profound medical prostate cancer innovation entrepreneurship

shared by Melissa Hughes on 29 Apr 13 - No Cached

Quest for a wonder drug started with shrew bait - The Globe and Mail - August 8, 2012 - 0 views

www.theglobeandmail.com/...article4470731

onocology Veronika Litinski life sciences clinical trials commericialization

shared by Assunta Krehl on 17 Aug 12 - No Cached

Assunta Krehl on 17 Aug 12

"Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.

<div class="cArrow"> </div><div class="cContentInner">"Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.</div>

...

Cancel

1 - 4 of 4

Showing 20▼ items per page

Related searches